Jan 18, 2020 3:59 AM
BACK TO TOP
KSE 100
43,167.77
102.67
(0.24%)
KSE ALL
29,998.45
83.98
(0.28%)
KSE 30
19,997.27
31.97
(0.16%)
KMI 30
70,276.42
172.53
(0.25%)
KMI ALL
20,240.95
68.78
(0.34%)
AGP Limited
PHARMACEUTICALS
Rs.106.92
-0.09
(-0.08%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, Jan 17, 2020 5:10 PM
REG
FUT
ODL
Open
107.00
High
109.49
Low
106.55
Volume
146,000
CIRCUIT BREAKER
101.66 — 112.36
DAY RANGE
106.55 — 109.49
52-WEEK RANGE
51.06 — 109.49
Ask Price
0.00
Ask Volume
0
Bid Price
106.92
Bid Volume
1,000
LDCP
107.01
VAR
25.00
HAIRCUT
32.50
P/E Ratio (TTM)
22.75
1-Year Change *
19.85%
YTD Change *
7.62%
Open
108.80
High
108.80
Low
106.00
Close
106.00
Change
-0.94%
LDCP
107.01
Volume
139
Total Trades
2
CIRCUIT BREAKER
96.31 — 117.71
DAY RANGE
106.00 — 108.80
Ask Price
108.49
Ask Volume
6
Bid Price
102.30
Bid Volume
10
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

AGP Limited was incorporated as a public limited company in May 2014 under the repealed Companies Ordinance. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale and manufacturing of pharmaceutical products. The Company is subsidiary of OBS Pakistan and the Ultimate Parent Company is West End 16 Pte Limited - Singapore.

KEY PEOPLE
Mr Tariq Moinuddin KhanChairman
Ms Nusrat MunshiCEO
Mr.Umair MukhtarCompany Secretary
ADDRESS

B-23-C, S.I.T.E, Karachi

WEBSITE

www.agp.com.pk

REGISTRAR

CDC Share Registrar Services Limited

AUDITOR

EY Ford Rhodes Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
29,937,600.00
Shares
280,000,000
Free Float
84,000,000
Free Float
30.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2019Transmission of Quarterly Report for the period ended September 30, 2019 View   PDF
Oct 30, 2019Financial Results for the Third Quarter ended September 30, 2019 View   PDF
Aug 29, 2019Transmission of Half yearly and Quarterly Report for the period ended June 30, 2019 View   PDF
Aug 6, 2019Financial Results for the half year and quarter ended June 30, 2019 View   PDF
Apr 30, 2019Transmission of Quarterly Report for the period ended March 31, 2019 View   PDF
Apr 26, 2019Financial Results for the quarter ended March 31, 2019 View   PDF
Mar 6, 2019Financial Results for the year ended December 31, 2018 View   PDF
Mar 5, 2019Financial Results for the year ending December 31, 2018 View   PDF
Oct 31, 2018Transmission of Third Quarterly Report for the Period Ended September 30, 2018 View   PDF
Oct 26, 2018Financial Results for September 30, 2018 View   PDF
DateTitleDocument
Dec 11, 2019Board Meeting in Progress View   PDF
Dec 4, 2019Board Meeting Other Than Financial Results View   PDF
Oct 29, 2019Board Meeting In Progress View   PDF
Oct 21, 2019Board Meeting View   PDF
Aug 5, 2019Board Meeting in Progress View   PDF
Jul 29, 2019Board Meeting for the half year ended June 30, 2019 View   PDF
Apr 25, 2019Board Meeting in Progress View   PDF
Apr 18, 2019Board Meeting for the first quarter ended March 31, 2019 View   PDF
Mar 26, 2019Notice of 5th Annual General Meeting View   PDF
Feb 25, 2019Annual Board Meeting for the year ended December 31, 2018 View   PDF
DateTitleDocument
Dec 19, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Dec 12, 2019Approval of Annual Budget View   PDF
Nov 22, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Oct 21, 2019Change of Company Secretary View   
Oct 10, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Oct 3, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Sep 13, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Sep 5, 2019Credit of Interim Cash Dividend View   PDF
Sep 4, 2019Prior notice of payment of interim cash dividend View   PDF
Sep 3, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2018201720162015
Sales5,382,0554,724,9904,205,750
Profit after Taxation1,206,6901,233,9041,087,080
EPS4.314.413.88
Q3 2019Q2 2019Q1 2019Q3 2018
Sales1,401,8491,558,5451,611,0091,168,422
Profit after Taxation320,734317,800425,297276,513
EPS1.151.131.520.99
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

201820172016
Gross Profit Margin (%)56.5060.8358.49
Net Profit Margin (%)22.4226.1125.85
EPS Growth (%)(2.27)13.66
PEG(8.95)

Payouts

DateFinancial ResultsDetailsBook Closure
August 6, 2019 3:32 PM30/06/2019(HYR) 12.50%(i) (D) 23/08/2019 - 29/08/2019
April 27, 2018 10:50 AM31/03/2018(IQ) 12.50% (D) 25/05/2018 - 01/06/2018

Financial Reports